Skip to main content
. 2021 Nov 15;40(4):412–418. doi: 10.1007/s11604-021-01214-5

Table 3.

Summary of patients with unsuccessful removal of central venous access parts

Patient
No.
Gender Age*1
(years)
BMI
(kg/m2)
Diagnosis Indwelling side Venous placement site Type of CV port Indication for removal Indwelling period (months) Removal procedure*3 Follow-up period*4 (months) Symptomatic late complication*5
(1)–(4) (5) (6) (7)
1 M 66 25.4 Lymphoma L Basilic DewX CR 41 + + 8 None
2 F 88 21.3 Lymphoma L Basilic DewX Infection*2 49 + + + 28 None
3 F 48 18.4 Leukemia L Basilic Vital-Port Other 58 + + 60 None
4 F 49 19.2 Laryngeal Ca L Basilic DewX CR 62 + + 7 None
5 F 42 19.9 Lymphoma L Brachial X-Port CR 70 + + 36 None
6 F 68 25.1 Lymphoma L Basilic Vital-Port CR 70 + + + 36 None
7 M 77 24.1 Pharyngeal Ca L Basilic Vital-Port CR 70 + + 33 None
8 M 45 21.5 Lymphoma L Basilic Vital-Port CR 78 + + 23 None
9 F 71 18.3 Lymphoma L Basilic X-Port CR 80 + + 9 None
10 M 39 23.9 Lymphoma L Cephalic Vital-Port CR 83 + + 21 None
11 F 70 20.9 Lymphoma L Basilic Vital-Port CR 83 + + 28 None
12 M 69 23.2 Extra-auditory Ca L Brachial Vital-Port CR 84 + + 41 None
13 F 44 22.9 Ovarian Ca L Basilic Vital-Port CR 87 + + 58 None
14 F 56 31.2 Myeloma L Basilic Vital-Port Occlusion 91 + 41 None
15 M 69 21.0 Lymphoma L Basilic Vital-Port CR 98 + + 2 None
16 F 53 19.7 Lymphoma L Basilic Vital-Port Occlusion 99 + + + + 54 None
17 M 67 24.6 Lymphoma L Basilic Celsite port Infection*2 109 + + + + 10 None
18 F 78 20.0 Lymphoma L Basilic Vital-Port Breakage 138 + 3 None

M male, F female, BMI body mass index, Ca carcinoma, L left, CV port central venous access port, CR complete response Vital-Port Mini Titanium Vital-Port, X-Port BARD X-Port, Celsiteport P-U Celsiteport

*1Age at removal of CV port

*2Possibility of infection from CV port

*3Refer to Materials and methods in the text for details of the removal procedure in (1)–(7)

*4The period after attempt to remove the CV port

*5The complication related to the catheter left in place

Died due to aggravated underlying disease